Results 11 to 20 of about 36,803 (257)

A Hybrid Automata Approach for Monitoring the Patient in the Loop in Artificial Pancreas Systems

Sensors, 2021
The use of automated insulin delivery systems has become a reality for people with type 1 diabetes (T1D), with several hybrid systems already on the market. One of the particularities of this technology is that the patient is in the loop. People with T1D
Aleix Beneyto, Vicenç Puig, B. Wayne Bequette, Josep Vehi   +3 more
doaj   +1 more source

Generation of Virtual Patient Populations That Represent Real Type 1 Diabetes Cohorts

Mathematics, 2021
Preclinical testing and validation of therapeutic strategies developed for patients with type 1 diabetes (T1D) require a cohort of virtual patients (VPs).
Sayyar Ahmad, Charrise M. Ramkissoon, Aleix Beneyto, Ignacio Conget, Marga Giménez, Josep Vehi   +5 more
doaj   +1 more source

Nurses’ Perception regarding Artificial Pancreas among Type I Diabetes Mellitus at the National Diabetic Institute [PDF]

Helwan International Journal for Nursing Research and Practice
Nurses’ Perception regarding Artificial Pancreas among Type I Diabetes Mellitus at the National Diabetic InstituteAhmed Saied Abdelaziz (1), Amany Mohamed Saad (2),Ons Said El-Zayat (3)(1) Infection control coordinator in 57357 hospital(2) Assistant ...
Ahmed Eltesh
doaj   +1 more source

Structured Educational Program about Artificial Pancreas for Patients with Type 1 Diabetes Mellitus [PDF]

Egyptian Journal of Health Care
Background: Artificial pancreases are medical devices designed to help patients with type 1diabetes manage blood sugar levels by monitoring glucose automatically and delivering insulin as needed.
Sahar Mahmoud S. El Awady, Badria Abd Elshahed Ahmed El-Kattan, Amel Abd El - Aaziem Mohamed, Ons Said Mohamed El-Zayat   +3 more
doaj   +1 more source

Lipohypertrophy and the Artificial Pancreas [PDF]

Journal of Diabetes Science and Technology, 2014
It is well known that repeated injections of insulin in the same skin region by people with diabetes induce local reactions of the subcutaneous adipose layer, most often lipohypertrophy (LHT).1,2 This also holds true for continuous subcutaneous insulin infusion (CSII) therapy in which the catheter of the insulin infusion set is frequently placed in the
Lutz, Heinemann, Larry, Hirsch, Roman, Hovorka   +2 more
openaire   +2 more sources

Identification of Movements and Postures Using Wearable Sensors for Implementation in a Bi-Hormonal Artificial Pancreas System

Sensors, 2021
Background: Closed loop bi-hormonal artificial pancreas systems, such as the artificial pancreas (AP™) developed by Inreda Diabetic B.V., control blood glucose levels of type 1 diabetes mellitus patients via closed loop regulation.
Ben Sawaryn, Michel Klaassen, Bert-Jan van Beijnum, Hans Zwart, Peter H. Veltink   +4 more
doaj   +1 more source

The Artificial Pancreas [PDF]

Diabetes, 2012
The discovery of insulin was lifesaving. However, it converted type 1 diabetes, which had been an acute and lethal disease, into a chronic disease, with its attendant complications. It had long been considered—and was clearly demonstrated in the Diabetes Control and Complications Trial (1)—that microvascular complications such as retinopathy ...
openaire   +2 more sources

Artificial Pancreas Control Strategies Used for Type 1 Diabetes Control and Treatment: A Comprehensive Analysis

Applied System Innovation, 2020
This paper presents a comprehensive survey about the fundamental components of the artificial pancreas (AP) system including insulin administration and delivery, glucose measurement (GM), and control strategies/algorithms used for type 1 diabetes ...
Sohaib Mehmood, Imran Ahmad, Hadeeqa Arif, Umm E Ammara, Abdul Majeed   +4 more
doaj   +1 more source

Performance Analysis of Different Embedded Systems and Open-Source Optimization Packages Towards an Impulsive MPC Artificial Pancreas

Frontiers in Endocrinology, 2021
Current technological advances have brought closer to reality the project of a safe, portable, and efficient artificial pancreas for people with type 1 diabetes (T1D).
Jhon E. Goez-Mora, María F. Villa-Tamayo, Monica Vallejo, Pablo S. Rivadeneira   +3 more
doaj   +1 more source

Closed-Loop Insulin Delivery Systems: Past, Present, and Future Directions

Frontiers in Endocrinology, 2022
Closed-loop (artificial pancreas) systems for automated insulin delivery have been likened to the holy grail of diabetes management. The first iterations of glucose-responsive insulin delivery were pioneered in the 1960s and 1970s, with the development ...
Sophie Templer
doaj   +1 more source